Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

SP-26 Achieves Major Preclinical Milestone, Paving the Way for First At-Home Ketamine Therapy for Fibromyalgia. Silo Pharma has just reported encouraging preclinical results for SP-26, its innovative ketamine-based implant designed for chronic pain, including fibromyalgia.